Crossmark

The many paths ascending to ferroptosis

Crossref DOI link: https://doi.org/10.1038/s41589-024-01794-z

Published Online: 2024-12-24

Published Print: 2025-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Conrad, Marcus https://orcid.org/0000-0003-1140-5612
Wahida, Adam https://orcid.org/0000-0002-8856-8834
License Information

Text and Data Mining valid from 2024-12-24

Version of Record valid from 2024-12-24
More Information

Article History

First Online: 24 December 2024

Competing interests

: M.C. is a co-founder and shareholder of ROSCUE Therapeutics GmbH and holds patents for some of the compounds described herein.